Case File
efta-efta01912974DOJ Data Set 10CorrespondenceEFTA Document EFTA01912974
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01912974
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
'
•
m[jeevacation@gmaitcom]
From:
Sent:
Fri 12/14/2012 9:56:35 AM
Subject:
Re:
Same here...will send you a list on glatiator hedge funds now.
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Friday, December 14, 2012 09:53 AM
To: Malek, Charly
Subject:
good fun thanks
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This communication is issued by UBS AG and/or affiliates to professional
investors only. This is not a personal recommendation, an offer to buy or sell
or a solicitation to buy or sell any securities, investment products or other
financial instrument or service. This communication is subject to terms
available at the following link:
www.ubs.com/salesandtradingdisclaimers
Intended for recipient only and not for further distribution without the consent
of UBS.
UBS Limited is a company limited by shares incorporated in the United Kingdom
registered in England and Wales with number 2035362.
Registered office: 1 Finsbury Avenue, London EC2M 2PP. UBS Limited is
authorised and regulated by the Financial Services Authority.
UBS AG (London Branch) is registered as a branch of a foreign company under
number BR004507, whose registered office is at 1 Finsbury Avenue, London, EC2M
2PP, United Kingdom.
UBS AG is a public company incorporated with limited liability in Switzerland
domiciled in the Canton of Basel-City and the Canton of Zurich respectively
EFTA_R1_00350782
EFTA01912974
registered at the Commercial Registry offices in those Cantons with
Identification No: CH-270.3.004.646-4 and having respective head offices at
Aeschenvorstadt 1, 4051 Basel and Bahnhofstrasse 45, 8001 Zurich, Switzerland.
Registered in the United Kingdom as a foreign company with No: FCO21146 and
having a UK Establishment registered at Companies House, Cardiff, with No:
BR 004507. The principal office of UK Establishment: 1 Finsbury Avenue, London
EC2M 2PP. In the United Kingdom, UBS AG is authorised and regulated by the
Financial Services Authority.
UBS reserves the right to retain all messages. Messages are protected and
accessed only in legally justified cases.
UBS 2012. All rights reserved.
EFTA_R1_00350783
EFTA01912975
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.